The combination of tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP-7) has been proposed as a more specific and sensitive biomarker for early detection of AKI [21]. This evidence concerns the gene IGFBP7 and acute kidney injury.